These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1510 related articles for article (PubMed ID: 25802423)

  • 41. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.
    Poli D; Antonucci E; Bertù L; Vignini E; Ruocco L; Mastroiacovo D; Paparo C; Pastori D; Testa S; Ageno W; Palareti G;
    Thromb Res; 2019 Nov; 183():28-32. PubMed ID: 31536872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism.
    Bertoletti L; Ollier E; Duvillard C; Delavenne X; Beyens MN; De Magalhaes E; Bellet F; Basset T; Mismetti P; Laporte S
    Pharmacol Res; 2017 Apr; 118():33-42. PubMed ID: 27350265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
    Bounameaux H; Haas S; Farjat AE; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Schellong S; Mantovani LG; Prandoni P; Kakkar AK
    Thromb Res; 2020 Jul; 191():103-112. PubMed ID: 32422442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism.
    Chen J; Bi G; Wu F; Qin X
    Pediatr Res; 2023 May; 93(6):1491-1498. PubMed ID: 36071237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France.
    Bertoletti L; Gusto G; Khachatryan A; Quignot N; Chaves J; Moniot A; Mokgokong R
    Thromb Haemost; 2022 Aug; 122(8):1384-1396. PubMed ID: 34983073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
    Patel A; Williams H; Baer MR; Zimrin AB; Law JY
    Acta Haematol; 2019; 142(4):233-238. PubMed ID: 31108496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex related differences in patients with acute venous thromboembolism treated with new oral anticoagulants. A meta-analysis of the interventional trials.
    Loffredo L; Violi F; Perri L
    Int J Cardiol; 2016 Jun; 212():255-8. PubMed ID: 27057930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trajectories of adherence to extended treatment with direct oral anticoagulants and risks of recurrent venous thromboembolism and major bleeding.
    Kang HR; Jones BL; Lo-Ciganic WH; DeRemer CE; Dietrich EA; Huang PL; Wilson DL; Park H
    J Manag Care Spec Pharm; 2023 Nov; 29(11):1219-1230. PubMed ID: 37889866
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis.
    Valeriani E; Porreca E; Weitz JI; Schulman S; Candeloro M; Di Nisio M
    J Thromb Haemost; 2020 Jul; 18(7):1661-1671. PubMed ID: 32202042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
    O'Connell C; Escalante CP; Goldhaber SZ; McBane R; Connors JM; Raskob GE
    Oncologist; 2021 Jan; 26(1):e8-e16. PubMed ID: 33275319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.
    Imberti D; Pomero F; Mastroiacovo D
    Blood Transfus; 2020 Jan; 18(1):49-57. PubMed ID: 31184579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
    Vedovati MC; Giustozzi M; Bonitta G; Agnelli G; Becattini C
    Thromb Res; 2018 Oct; 170():175-180. PubMed ID: 30196195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.
    Wang W; Su Y; Wu C; Sun Y; Dai N; Chen W; Zhang J; Xu Y; Brindis RG; Xu D; Li J
    BMC Cardiovasc Disord; 2020 Feb; 20(1):53. PubMed ID: 32013892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Vedovati MC; Giustozzi M; Becattini C
    Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New anticoagulants in the management of venous thromboembolism in women.
    Piovella F; Irina Iosub D
    Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism.
    Fang MC; Reynolds K; Fan D; Prasad PA; Sung SH; Portugal C; Garcia E; Go AS
    JAMA Netw Open; 2023 Aug; 6(8):e2328033. PubMed ID: 37581888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials.
    Brunetti ND; Tricarico L; Correale M; De Gennaro L; Santoro F; Ieva R; Di Biase M
    J Thromb Thrombolysis; 2020 Aug; 50(2):305-310. PubMed ID: 31654194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
    Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
    Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer.
    Abdulla A; Davis WM; Ratnaweera N; Szefer E; Ballantyne Scott B; Lee AYY
    Thromb Haemost; 2020 Apr; 120(4):702-713. PubMed ID: 32289865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.